Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Illumina, Inc.    ILMN   US4523271090

ILLUMINA, INC. (ILMN)

39
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2014 07/22/2014 07/23/2014 07/24/2014 07/25/2014 Date
175.89(c) 176.31(c) 180.64(c) 171.8(c) 171.03(c) Last
1 132 391 870 776 1 912 083 2 830 134 1 128 333 Volume
+1.06% +0.24% +2.46% -4.89% -0.45% Change
More quotes
Company
Illumina, Inc. develops, manufactures and markets life science tools and integrated systems for the analysis of genetic variation and function. The company provides sequencing and array-based solutions for genotyping, copy-number variation analysis, methylation studies and gene expression profiling... 
Surperformance© rating of Illumina, Inc.
Trading Rating : Investor Rating :
More about the company
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 1 799 M
EBIT 2014 495 M
Net income 2014 245 M
Debt 2014 529 M
Yield 2014 -
Sales 2015 2 159 M
EBIT 2015 610 M
Net income 2015 340 M
Debt 2015 202 M
Yield 2015 -
PER 2014 103,65
PER 2015 74,83
EV / Sales 2014 12,5x
EV / Sales 2015 10,3x
Capitalization 21 960 M
More Financials
Latest news on ILLUMINA, INC.
1d ago ILLUMINA : Presolicitation Notice - NextSeq 500 DNA Sequencer
3d ago ILLUMINA : Patent Issued for Patterned Flow-Cells Useful for Nucleic Acid Analys..
3d ago ILLUMINA : Results of Operations and Financial Condition, Financial Statements a..
3d ago ILLUMINA : Reports Strong Financial Results for Second Quarter of Fiscal Year 20..
3d ago ILLUMINA : Presolicitation Notice - ILLUMINA TRUSEQ NANO DNA LT SAMPLE LIT-SET A
3d ago ILLUMINA : Presolicitation Notice - ILLUMINA TRUSEQ RAPID SBS KIT HS (200 CYCLE)
4d ago ILLUMINA : Sidra to Help Qatar Grow as a Hub for Genetic Medicine
5d ago ILLUMINA : Special Notice - 66-- Notice of Intent to Sole Source - MiSeq by Illu..
5d ago ILLUMINA : MiSeq System Sought by Health and Human Services
5d ago ILLUMINA : Berry Genomics and Illumina Co-Develop Integrated Next-Generation Seq..
5d ago ILLUMINA : Buys Myraqa
07/18 ILLUMINA : Combine Solicitation - R-- 618-14-2-655-0192 Genotyping Services
More news
4-Traders Strategies on ILLUMINA, INC. 
2013End of the technical recovery
More Strategies
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Illumina, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Illumina, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF